Chapter 2 - University of British Columbia
Chapter 2 - University of British Columbia
Chapter 2 - University of British Columbia
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A<br />
2001, 98(19):10869-10874.<br />
18. Fukumoto S, Yamauchi N, Moriguchi H, Hippo Y, Watanabe A, Shibahara J, Taniguchi<br />
H, Ishikawa S, Ito H, Yamamoto S et al: Overexpression <strong>of</strong> the aldo-keto reductase<br />
family protein AKR1B10 is highly correlated with smokers' non-small cell lung<br />
carcinomas. Clin Cancer Res 2005, 11(5):1776-1785.<br />
19. Heighway J, Knapp T, Boyce L, Brennand S, Field JK, Betticher DC, Ratschiller D,<br />
Gugger M, Donovan M, Lasek A et al: Expression pr<strong>of</strong>iling <strong>of</strong> primary non-small cell<br />
lung cancer for target identification. Oncogene 2002, 21(50):7749-7763.<br />
20. Hu J, Bianchi F, Ferguson M, Cesario A, Margaritora S, Granone P, Goldstraw P, Tetlow<br />
M, Ratcliffe C, Nicholson AG et al: Gene expression signature for angiogenic and<br />
nonangiogenic non-small-cell lung cancer. Oncogene 2005, 24(7):1212-1219.<br />
21. Larsen JE, Pavey SJ, Passmore LH, Bowman R, Clarke BE, Hayward NK, Fong KM:<br />
Expression pr<strong>of</strong>iling defines a recurrence signature in lung squamous cell<br />
carcinoma. Carcinogenesis 2007, 28(3):760-766.<br />
22. Larsen JE, Pavey SJ, Passmore LH, Bowman RV, Hayward NK, Fong KM: Gene<br />
expression signature predicts recurrence in lung adenocarcinoma. Clin Cancer<br />
Res 2007, 13(10):2946-2954.<br />
23. Lau SK, Boutros PC, Pintilie M, Blackhall FH, Zhu CQ, Strumpf D, Johnston MR, Darling<br />
G, Keshavjee S, Waddell TK et al: Three-gene prognostic classifier for early-stage<br />
non small-cell lung cancer. J Clin Oncol 2007, 25(35):5562-5569.<br />
24. Oshita F, Ikehara M, Sekiyama A, Hamanaka N, Saito H, Yamada K, Noda K, Kameda<br />
Y, Miyagi Y: Genomic-wide cDNA microarray screening to correlate gene<br />
expression pr<strong>of</strong>ile with chemoresistance in patients with advanced lung cancer. J<br />
Exp Ther Oncol 2004, 4(2):155-160.<br />
25. Potti A, Mukherjee S, Petersen R, Dressman HK, Bild A, Koontz J, Kratzke R, Watson<br />
MA, Kelley M, Ginsburg GS et al: A genomic strategy to refine prognosis in earlystage<br />
non-small-cell lung cancer. N Engl J Med 2006, 355(6):570-580.<br />
26. Raponi M, Zhang Y, Yu J, Chen G, Lee G, Taylor JM, Macdonald J, Thomas D,<br />
Moskaluk C, Wang Y et al: Gene expression signatures for predicting prognosis <strong>of</strong><br />
squamous cell and adenocarcinomas <strong>of</strong> the lung. Cancer Res 2006, 66(15):7466-<br />
7472.<br />
27. Remmelink M, Mijatovic T, Gustin A, Mathieu A, Rombaut K, Kiss R, Salmon I,<br />
Decaestecker C: Identification by means <strong>of</strong> cDNA microarray analyses <strong>of</strong> gene<br />
expression modifications in squamous non-small cell lung cancers as compared<br />
to normal bronchial epithelial tissue. Int J Oncol 2005, 26(1):247-258.<br />
28. Singhal S, Amin KM, Kruklitis R, DeLong P, Friscia ME, Litzky LA, Putt ME, Kaiser LR,<br />
Albelda SM: Alterations in cell cycle genes in early stage lung adenocarcinoma<br />
identified by expression pr<strong>of</strong>iling. Cancer Biol Ther 2003, 2(3):291-298.<br />
29. Spira A, Beane JE, Shah V, Steiling K, Liu G, Schembri F, Gilman S, Dumas YM, Calner<br />
P, Sebastiani P et al: Airway epithelial gene expression in the diagnostic evaluation<br />
<strong>of</strong> smokers with suspect lung cancer. Nat Med 2007, 13(3):361-366.<br />
30. Sun Z, Wigle DA, Yang P: Non-overlapping and non-cell-type-specific gene<br />
expression signatures predict lung cancer survival. J Clin Oncol 2008, 26(6):877-<br />
883.<br />
31. Wang T, Hopkins D, Schmidt C, Silva S, Houghton R, Takita H, Repasky E, Reed SG:<br />
Identification <strong>of</strong> genes differentially over-expressed in lung squamous cell<br />
carcinoma using combination <strong>of</strong> cDNA subtraction and microarray analysis.<br />
Oncogene 2000, 19(12):1519-1528.<br />
32. Wikman H, Seppanen JK, Sarhadi VK, Kettunen E, Salmenkivi K, Kuosma E, Vainio-<br />
Siukola K, Nagy B, Karjalainen A, Sioris T et al: Caveolins as tumour markers in lung<br />
cancer detected by combined use <strong>of</strong> cDNA and tissue microarrays. J Pathol 2004,<br />
203(1):584-593.<br />
19